Navigating weight loss: The employer’s guide to a new comprehensive weight care agenda
Navigating Weight Loss:
The employer's guide to a new comprehensive weight care agenda
Sponsored by
The president of Omada Health talks about why decision makers need to be thinking about holistic weight-management care as the demand for related medication grows.
Employees who eat a healthy diet are 25% more likely to have higher job performance and increased cognitive function.
The increased popularity of GLP-1s for weight loss has pushed organizations to modify their healthcare plans.
The chief commercial officer at Form Health advises benefit managers to take a close look at vendors and employee needs to make sure intentions align.
Nearly all employers plan to maintain and even expand their well-being benefits, despite healthcare costs and economic uncertainty.
The class of weight loss medication is seeing a spike in consumer popularity, driving employers to explore what the path to adoption looks like.
In EBN's first digital magazine of 2025, employers are ready to help employees stick to their resolutions around health and well-being.
On-site access to healthcare keeps workers and their families up to date on their health and ahead of major issues.
Data shows a noticeable decline in obesity among those taking medications such as Ozempic and Zepbound.
These efforts and expectations center around improving health outcomes while cutting costs.
Eli Lilly will begin offering vials of its best-selling weight-loss drug, Zepbound, through Ro's telehealth platform.
By focusing on behavioral changes around food, people are better able to lose weight and keep it off long-term.